CoChat

Rhabdomyolysis from the Coadministration of Lovastatin and the Antifungal Agent Itraconazole

Open access
Lees, Robert S., Lees, Ann M. · 1995 · New England Journal of Medicine

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

To the Editor: Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, widely prescribed to treat hypercholesterolemia, are clearly effective and are associated with reductions in mortality from coronary disease and overall mortality.1 Toxic effects on skeletal muscle, which may range from diffuse myalgia to severe rhabdomyolysis, are a known side effect of these drugs. 2 Interactions of HMG-CoA reductase inhibitors with cyclosporine, and less often with gemfibrozil and niacin, increase the risk of rhabdomyolysis.2 We report a case of severe rhabdomyolysis from the coadministration of lovastatin, niacin, and itraconazole.A 63-year-old woman with familial hypercholesterolemia and a previous myocardial infarction who had undergone coronary-artery bypass surgery at the age of 50, was treated with 80 mg of lovastatin and 3 g of niacin daily, plus timolol maleate and aspirin, for almost 10 years without evidence of toxic effects.In March 1995, scaling lesions developed on her abdomen.A dermatologist diagnosed tinea corporis and prescribed 100 mg of itraconazole (Sporanox) twice daily.The patient was advised to continue her regular medications.Two weeks later weakness developed in her arms, back, and legs, along with pain on motion and tenderness to touch.After 2 1 ⁄ 2 weeks, when her urine turned dark, then frankly brown, the patient sought medical attention.On examination, her muscles were tender and very weak.Her urine was brown, cloudy, and strongly positive for heme.Treatment with itraconazole, lovastatin, and niacin was stopped immediately, and treatment with 210 mg of oral ubiquinone (coenzyme Q) daily was begun.Ubiquinone has been reported to ameliorate the toxic effects of lovastatin.3 Blood counts and renal-function tests were normal.The serum concentration of aldolase (specific for skeletal muscle) was 75 U per liter (10 times the normal value).Initial values for serum creatine kinase, aspartate aminotransferase, alanine aminotransferase, and lactate dehydrogenase were 32,700, 1145, 382, and 1225 U per liter, respectively, and over the next four days these values peaked at 47,100, 1390, 581, and 2217 U per liter.A diagnosis of drug-induced rhabdomyolysis and hepatotoxicity was made.Over the next 18 days, the elevated serum enzyme values gradually returned to normal, and the symptoms disappeared; ubiquinone was then stopped.The patient's plasma cholesterol level, which was 253 mg per deciliter while she was taking lovastatin but before the itraconazole therapy, was 193 mg per deciliter while she was taking both lovastatin and itraconazole, and it gradually rose to 465 mg per deciliter after both drugs were discontinued.Niacin therapy (3 g daily) was started again 11 weeks later, without evidence of toxicity.This patient had severe rhabdomyolysis when itraconazole was added to a stable regimen that included lovastatin as well as niacin.Both the cholesterol-lowering statins (lovastatin, pravastatin, simvastatin, and fluvastatin) and the antifungal azoles (itraconazole, ketoconazole, clotrimazole, and miconazole) inhibit sterol synthesis.4 However, the cause of our patient's toxic reaction is not clear, and it is also not clear whether ubiquinone modified the course of that reaction.Since cholesterol-lowering therapy can safely be suspended for short periods, it seems prudent either to discontinue treatment with statins temporarily while using itraconazole and similar drugs or to use alternative antifungal therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm199509073331015

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 13

  1. Linn ES. Clinical significance of the androgenicity of progestins in hormonal therapy in women. Clin Ther 1990;12:447-55.
  2. O'Sullivan AJ, Kelly JJ, Hoffman DM, Freund J, Ho KKY. Body composition and energy expenditure in acromegaly. J Clin Endocrinol Metab 1994;78:381- 6.
  3. Weinstein I, Soler-Argilaga C, Werner HV, Heimberg M. Effects of ethynyl- oestradiol on the metabolism of [1-14 C] oleate by perfused livers and hepato- cytes from female rats. Biochem J 1979;180:265-71.
  4. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabo- lism of plasma lipoproteins. N Engl J Med 1991;325:1196-204.
  5. Jensen MD, Martin ML, Cryer PE, Roust LR. Effects of estrogen on free fatty acid metabolism in humans. Am J Physiol 1994;266:E914-E920.
  6. Hoover DR, Saah AJ, Bacellar H, et al. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. N Engl J Med 1993;329:1922-6.
  7. Pertel P, Hirschtick JP, Phair J, Chmiel J, Poggensee L, Murphy R. Risk of developing cytomegalovirus retinitis in persons infected with the human im- munodeficiency virus. J Acquir Immune Defic Syndr 1992;5:1069-74.
  8. Kuppermann BD, Petty JG, Richman DD, et al. Correlation between CD4ϩ counts and prevalence of cytomegalovirus retinitis and human immunodefi- ciency virus-related noninfectious retinal vasculopathy in patients with ac- quired immunodeficiency syndrome. Am J Ophthalmol 1993;115:575-82.
  9. Grinspoon L, Bakalar JB. Marihuana, the forbidden medicine. New Haven: Yale University Press, 1993.
  10. Idem. Marihuana as medicine: a plea for reconsideration. JAMA 1995;273: 1875-6.
  11. Marijuana scheduling petition: denial of petition: remand. Fed Regist 1992; 57:10503.
  12. 1994, Lancet, 344, 1383
  13. Illingworth DR, 1994, Clin Ther, 16, 366

Cited by

See all 136

Metadata

Authors
Lees, R. S., & Lees, A. M.
Venue
New England Journal of Medicine
Published
1995-09-07
Volume
333
Issue
10
Pages
664-665
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2037324447
Cited by
136
References
3
Citations by year
2025: 1 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 2 · 2016: 3 · 2015: 2 · 2014: 1 · 2013: 1 · 2012: 1
FWCI
13.61
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Muscle and Compartmental Disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
Keywords
rhabdomyolysis, lovastatin, itraconazole, nicotinic acid, drug-drug interactions, statins, statin toxicity, antifungal agents, familial hypercholesterolemia, coenzyme Q10, tinea corporis, muscle toxicity, adverse drug reactions, hypercholesterolemia treatment, cyclosporine
MeSH terms
Drug Interactions, Female, Humans, Lovastatin, Middle Aged, Niacin, Rhabdomyolysis, Itraconazole

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rhabdomyolysis from the Coadministration of Lovastatin and the Antifungal Agent Itraconazole. https://app.cochat.ai/papers/10.1056/nejm199509073331015
The paper
Lees, R. S., & Lees, A. M. (1995). Rhabdomyolysis from the Coadministration of Lovastatin and the Antifungal Agent Itraconazole. New England Journal of Medicine. https://doi.org/10.1056/nejm199509073331015

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.